ADAM17 and pancreatic serous cystadenoma: To address this in more detail we next evaluated the different hepatic immune cell populations of PBC and PSC patients for ADAM17 expression; specifically CD4+ T cells, CD8+ T cells, and monocytes/macrophages (CD68+ cells) which are known to express ADAM17 (42, 43).